OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
137940$263.0056

Next Eye Co Ltd

Industrial Machinery & EquipmentVerified

Next Eye Co Ltd exhibits a weak capital structure and liquidity position, with a price-to-book ratio of 0.51 and a price-to-tangible-book ratio of 0.51, indicating undervaluation relative to its book value. The company's debt-to-equity ratio of 0.38 suggests moderate leverage, but its negative operating cash flow of -16,366,084,840 KRW and free cash flow of -39,684,238,450 KRW highlight significant liquidity constraints. Profitability metrics are severely underperforming compared to industry norms. The company reported a net loss of -40,081,158,830 KRW and an operating loss of -37,957,291,100 KRW, with a return on equity of -0.9322 and a return on assets of -0.4203. These figures indicate a substantial deviation from the industry's preferred metrics of profitability and returns. The company's revenue is derived from two primary segments: inspection equipment and cosmetics. While the inspection equipment segment is its core business, the cosmetics segment contributes to diversification. However, the financial data does not provide specific revenue breakdowns by segment or geography, making it difficult to assess concentration risks. Growth trajectory is negative, with the company reporting declining revenues and increasing losses. The outlook for the current fiscal year and the next fiscal year is not explicitly provided, but the negative operating and free cash flows suggest a challenging growth environment. The company's historical performance indicates a need for significant operational improvements to achieve positive growth. Risk factors include low liquidity and the potential for dilution, although no immediate filing-based liquidity or dilution flags were detected. The company's negative operating cash flow and free cash flow indicate a high liquidity risk, which could necessitate additional financing or equity dilution in the near term. Recent events and filings do not provide specific details on the company's strategic initiatives or operational changes. The absence of detailed information on recent events makes it difficult to assess the company's response to market conditions and its ability to address its financial challenges.

30-day price · 137940-8.00 (-3.0%)
Low$235.00High$294.00Close$263.00As of25 May, 00:00 UTC
Profile
CompanyNext Eye Co Ltd
Ticker137940.KQ
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryIndustrial Machinery & Equipment
AI analysis

Business. Next Eye Co Ltd is a Korea-based company engaged in the manufacturing and sale of inspection equipment, including polarizing film inspection equipment for display, glass cracking inspection equipment, 3D measuring instruments, and frame grabber, as well as cosmetics wholesale and retail.

Classification. Next Eye Co Ltd is classified under the Industrials economic sector, Industrial Goods business sector, and Industrial Machinery & Equipment industry with a confidence level of 0.92.

Next Eye Co Ltd exhibits a weak capital structure and liquidity position, with a price-to-book ratio of 0.51 and a price-to-tangible-book ratio of 0.51, indicating undervaluation relative to its book value. The company's debt-to-equity ratio of 0.38 suggests moderate leverage, but its negative operating cash flow of -16,366,084,840 KRW and free cash flow of -39,684,238,450 KRW highlight significant liquidity constraints. Profitability metrics are severely underperforming compared to industry norms. The company reported a net loss of -40,081,158,830 KRW and an operating loss of -37,957,291,100 KRW, with a return on equity of -0.9322 and a return on assets of -0.4203. These figures indicate a substantial deviation from the industry's preferred metrics of profitability and returns. The company's revenue is derived from two primary segments: inspection equipment and cosmetics. While the inspection equipment segment is its core business, the cosmetics segment contributes to diversification. However, the financial data does not provide specific revenue breakdowns by segment or geography, making it difficult to assess concentration risks. Growth trajectory is negative, with the company reporting declining revenues and increasing losses. The outlook for the current fiscal year and the next fiscal year is not explicitly provided, but the negative operating and free cash flows suggest a challenging growth environment. The company's historical performance indicates a need for significant operational improvements to achieve positive growth. Risk factors include low liquidity and the potential for dilution, although no immediate filing-based liquidity or dilution flags were detected. The company's negative operating cash flow and free cash flow indicate a high liquidity risk, which could necessitate additional financing or equity dilution in the near term. Recent events and filings do not provide specific details on the company's strategic initiatives or operational changes. The absence of detailed information on recent events makes it difficult to assess the company's response to market conditions and its ability to address its financial challenges.
Key takeaways
  • Next Eye Co Ltd is operating at a significant loss, with a net income of -40,081,158,830 KRW and an operating income of -37,957,291,100 KRW.
  • The company's liquidity position is weak, as evidenced by negative operating and free cash flows.
  • The price-to-book ratio of 0.51 suggests the company is undervalued relative to its book value.
  • The company's debt-to-equity ratio of 0.38 indicates moderate leverage, but its negative cash flows pose a liquidity risk.
  • No immediate filing-based liquidity or dilution flags were detected, but the company's financial performance suggests potential future dilution.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$120.06B
Gross profit$92.42B
Operating income-$37.96B
Net income-$40.08B
R&D
SG&A
D&A
SBC
Operating cash flow-$16.37B
CapEx-$312.2M
Free cash flow-$39.68B
Total assets$95.36B
Total liabilities$52.37B
Total equity$43.00B
Cash & equivalents$20.61B
Long-term debt$16.31B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$263.00
Market cap$21.99B
Enterprise value$17.68B
P/E
Reported non-GAAP P/E
EV/Revenue0.1
EV/Op income
EV/OCF
P/B0.5
P/Tangible book0.5
Tangible book$43.00B
Net cash$4.31B
Current ratio1.0
Debt/Equity0.4
ROA-42.0%
ROE-93.2%
Cash conversion41.0%
CapEx/Revenue-0.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Industrial Goods · cohort 13 companies
Metric137940Activity
Op margin-31.6%9.4% medp25 9.4% · p75 9.4%bottom quartile
Net margin-33.4%5.8% medp25 5.8% · p75 5.8%bottom quartile
Gross margin77.0%26.9% medp25 26.9% · p75 26.9%top quartile
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-0.3%2.4% medp25 1.6% · p75 3.3%bottom quartile
Debt / equity38.0%106.4% medp25 106.4% · p75 106.4%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 20:17 UTC#1374d86d
Market quoteclose KRW 263.00 · shares 0.08B diluted
no public URL
2026-05-04 20:17 UTC#9e729ee7
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 20:18 UTCJob: 144280fb